{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:27:03Z","timestamp":1720657623790},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,10]]},"DOI":"10.7759\/cureus.64269","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:18:25Z","timestamp":1720646305000},"source":"Crossref","is-referenced-by-count":0,"title":["A Unique Case of Goodpasture\u2019s Syndrome-Induced Cardiorenal Syndrome"],"prefix":"10.7759","author":[{"given":"Chidambaram","family":"Chinniah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Pyronneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauthier","family":"Stepman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rias","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103212","article-title":"Anti-glomerular basement membrane vasculitis","volume":"22","author":"Ponticelli C","year":"2023","unstructured":"Ponticelli C, Calatroni M, Moroni G. Anti-glomerular basement membrane vasculitis. Autoimmun Rev. 2023, 22:103212. 10.1016\/j.autrev.2022.103212","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S326427","article-title":"Epidemiology, impact, and management strategies of anti-glomerular basement membrane disease","volume":"15","author":"Asim M","year":"2022","unstructured":"Asim M, Akhtar M. Epidemiology, impact, and management strategies of anti-glomerular basement membrane disease. Int J Nephrol Renovasc Dis. 2022, 15:129-38. 10.2147\/IJNRD.S326427","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.582272","article-title":"Glomerulonephritis in AKI: from pathogenesis to therapeutic intervention","volume":"7","author":"Pesce F","year":"2020","unstructured":"Pesce F, Stea ED, Rossini M, et al.. Glomerulonephritis in AKI: from pathogenesis to therapeutic intervention. Front Med (Lausanne). 2020, 7:582272. 10.3389\/fmed.2020.582272","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette JC","year":"2003","unstructured":"Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003, 63:1164-77. 10.1046\/j.1523-1755.2003.00843.x","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.375","article-title":"Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease","volume":"83","author":"Tang W","year":"2013","unstructured":"Tang W, McDonald SP, Hawley CM, et al.. Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. Kidney Int. 2013, 83:503-10. 10.1038\/ki.2012.375","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6516.301","article-title":"Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4","volume":"292","author":"Savage CO","year":"1986","unstructured":"Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed). 1986, 292:301-4. 10.1136\/bmj.292.6516.301","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy JB","year":"2001","unstructured":"Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001, 134:1033-42. 10.7326\/0003-4819-134-11-200106050-00009","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000348479","article-title":"Management of crescentic glomerulonephritis: what are the recent advances?","volume":"181","author":"Li X","year":"2013","unstructured":"Li X, Chen N. Management of crescentic glomerulonephritis: what are the recent advances?. Contrib Nephrol. 2013, 181:229-39. 10.1159\/000348479","journal-title":"Contrib Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2019.04.001","article-title":"Cardiorenal syndrome: pathophysiology","volume":"37","author":"Kumar U","year":"2019","unstructured":"Kumar U, Wettersten N, Garimella PS. Cardiorenal syndrome: pathophysiology. Cardiol Clin. 2019, 37:251-65. 10.1016\/j.ccl.2019.04.001","journal-title":"Cardiol Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.23265","article-title":"Cardiorenal syndrome: pathophysiology as a key to the therapeutic approach in an under-diagnosed disease","volume":"50","author":"Prastaro M","year":"2022","unstructured":"Prastaro M, Nardi E, Paolillo S, et al.. Cardiorenal syndrome: pathophysiology as a key to the therapeutic approach in an under-diagnosed disease. J Clin Ultrasound. 2022, 50:1110-24. 10.1002\/jcu.23265","journal-title":"J Clin Ultrasound"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115625","article-title":"Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen","volume":"89","author":"Turner N","year":"1992","unstructured":"Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, Pusey CD. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest. 1992, 89:592-601. 10.1172\/JCI115625","journal-title":"J Clin Invest"},{"key":"ref12","article-title":"Dilated cardiomyopathy in a patient with antibody-negative Goodpasture's syndrome and pulmonary relapse","volume":"21","author":"Solak Y","year":"2010","unstructured":"Solak Y, Selcuk NY, Polat I, Atalay H, Turkmen K. Dilated cardiomyopathy in a patient with antibody-negative Goodpasture's syndrome and pulmonary relapse. Saudi J Kidney Dis Transpl. 2010, 21:332-6.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2324709613480346","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi S","year":"2013","unstructured":"Dhesi S, Chu MP, Blevins G, Paterson I, Larratt L, Oudit GY, Kim DH. Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management. J Investig Med High Impact Case Rep. 2013, 1:10.1177\/2324709613480346","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.3371","article-title":"Diagnosis and treatment of acute myocarditis: a review","volume":"329","author":"Ammirati E","year":"2023","unstructured":"Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA. 2023, 329:1098-113. 10.1001\/jama.2023.3371","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2114478","article-title":"Myocarditis","volume":"387","author":"Basso C","year":"2022","unstructured":"Basso C. Myocarditis. N Engl J Med. 2022, 387:1488-500. 10.1056\/NEJMra2114478","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010150","article-title":"Myocarditis and chronic inflammatory cardiomyopathy, from acute inflammation to chronic inflammatory damage: an update on pathophysiology and diagnosis","volume":"13","author":"Uccello G","year":"2023","unstructured":"Uccello G, Bonacchi G, Rossi VA, Montrasio G, Beltrami M. Myocarditis and chronic inflammatory cardiomyopathy, from acute inflammation to chronic inflammatory damage: an update on pathophysiology and diagnosis. J Clin Med. 2023, 13:150. 10.3390\/jcm13010150","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00360-y","article-title":"Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes","volume":"5","author":"Hang W","year":"2020","unstructured":"Hang W, Chen C, Seubert JM, Wang DW. Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes. Signal Transduct Target Ther. 2020, 5:287. 10.1038\/s41392-020-00360-y","journal-title":"Signal Transduct Target Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101718","article-title":"Cardiac involvement in systemic and local vasculitides: the value of noninvasive multimodality imaging","volume":"48","author":"Ali AM","year":"2023","unstructured":"Ali AM, Yakupoglu HY, Fuchs TA, Larsen TH, Aukrust P, Gunnarsson R, Saeed S. Cardiac involvement in systemic and local vasculitides: the value of noninvasive multimodality imaging. Curr Probl Cardiol. 2023, 48:101718. 10.1016\/j.cpcardiol.2023.101718","journal-title":"Curr Probl Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2013.10.006","article-title":"The heart in vasculitis","volume":"40","author":"Miloslavsky E","year":"2014","unstructured":"Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am. 2014, 40:11-26. 10.1016\/j.rdc.2013.10.006","journal-title":"Rheum Dis Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac009","article-title":"Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?","volume":"15","author":"Floyd L","year":"2022","unstructured":"Floyd L, Morris AD, Woywodt A, Dhaygude A. Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?. Clin Kidney J. 2022, 15:618-23. 10.1093\/ckj\/sfac009","journal-title":"Clin Kidney J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7749","article-title":"An unusual case of heart failure due to ANCA-negative vasculitis: a case report and focused review of the literature","volume":"11","author":"Orlando PB","year":"2023","unstructured":"Orlando PB, Ines SG, Eduardo RV, Fernanda \u00c1BM. An unusual case of heart failure due to ANCA-negative vasculitis: a case report and focused review of the literature. Clin Case Rep. 2023, 11:e7749. 10.1002\/ccr3.7749","journal-title":"Clin Case Rep"},{"key":"ref22","article-title":"A rare case of anti-GBM negative Goodpasture disease presenting with dilated cardiomyopathy and perforating dermatoses","volume":"67","author":"Mandal C","year":"2019","unstructured":"Mandal C, Das S, Sarkar N. A rare case of anti-GBM negative Goodpasture disease presenting with dilated cardiomyopathy and perforating dermatoses. J Assoc Physicians India. 2019, 67:11-2.","journal-title":"J Assoc Physicians India"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2990","article-title":"Mid-ventricle takotsubo in a patient with Goodpasture syndrome","volume":"10","author":"Zablah G","year":"2018","unstructured":"Zablah G, Monta\u00f1ez-Valverde RA, Hurtado-de-Mendoza D, Colombo R. Mid-ventricle takotsubo in a patient with Goodpasture syndrome. Cureus. 2018, 10:e2990. 10.7759\/cureus.2990","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.024","article-title":"Diagnosis and classification of Goodpasture's disease (anti-GBM)","volume":"48-49","author":"Hellmark T","year":"2014","unstructured":"Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun. 2014, 48-49:108-12. 10.1016\/j.jaut.2014.01.024","journal-title":"J Autoimmun"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6820","article-title":"Use of rituximab in management of rapidly progressive glomerulonephritis","volume":"12","author":"Cancarevic I","year":"2020","unstructured":"Cancarevic I, Malik BH. Use of rituximab in management of rapidly progressive glomerulonephritis. Cureus. 2020, 12:e6820. 10.7759\/cureus.6820","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.04.003","article-title":"Rituximab in anti-GBM disease: a retrospective study of 8 patients","volume":"60","author":"Touzot M","year":"2015","unstructured":"Touzot M, Poisson J, Faguer S, et al.. Rituximab in anti-GBM disease: a retrospective study of 8 patients. J Autoimmun. 2015, 60:74-9. 10.1016\/j.jaut.2015.04.003","journal-title":"J Autoimmun"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017801","article-title":"Rituximab in treatment of anti-GBM antibody glomerulonephritis: a case report and literature review","volume":"98","author":"Uematsu-Uchida M","year":"2019","unstructured":"Uematsu-Uchida M, Ohira T, Tomita S, Satonaka H, Tojo A, Ishimitsu T. Rituximab in treatment of anti-GBM antibody glomerulonephritis: a case report and literature review. Medicine (Baltimore). 2019, 98:e17801. 10.1097\/MD.0000000000017801","journal-title":"Medicine (Baltimore)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1038-7","article-title":"Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease","volume":"19","author":"Heitz M","year":"2018","unstructured":"Heitz M, Carron PL, Clavarino G, Jouve T, Pinel N, Guebre-Egziabher F, Rostaing L. Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease. BMC Nephrol. 2018, 19:241. 10.1186\/s12882-018-1038-7","journal-title":"BMC Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.07.019","article-title":"Advances in understanding of pathogenesis and treatment of immune-mediated kidney disease: a review","volume":"79","author":"Kant S","year":"2022","unstructured":"Kant S, Kronbichler A, Sharma P, Geetha D. Advances in understanding of pathogenesis and treatment of immune-mediated kidney disease: a review. Am J Kidney Dis. 2022, 79:582-600. 10.1053\/j.ajkd.2021.07.019","journal-title":"Am J Kidney Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq115","article-title":"Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes","volume":"25","author":"Yang R","year":"2010","unstructured":"Yang R, Otten MA, Hellmark T, et al.. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant. 2010, 25:2479-86. 10.1093\/ndt\/gfq115","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/156076-a-unique-case-of-goodpastures-syndrome-induced-cardiorenal-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:18:29Z","timestamp":1720646309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/156076-a-unique-case-of-goodpastures-syndrome-induced-cardiorenal-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.64269","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}